-+ 0.00%
-+ 0.00%
-+ 0.00%

Telix Stock And 2 Australian Miners With High Insider Ownership And Fast Growth

Simply Wall St·07/28/2026 23:28:27
语音播报

With inflation trends, central bank moves and bond yields all pulling markets in different directions, many investors are looking for companies that can grow through mixed conditions and where insiders still have meaningful skin in the game. Fast growing stocks with high insider ownership can offer that combination, because management is signaling confidence in the same outlook that analysts are watching closely. This article explains why that theme can be appealing in the current environment and highlights 3 stocks from the Fast Growing Stocks With High Insider Ownership screener that fit those characteristics.

Predictive Discovery (ASX:PDI)

Overview: Predictive Discovery is an Australia based gold company focused on exploring and developing large scale gold reserves in West Africa, with its flagship Bankan Gold project in north east Guinea and producing mines at Kiniero and Nampala.

Market Cap: A$3.24b

Predictive Discovery gives you exposure to a fast growing West African gold portfolio anchored by two producing mines and the large Bankan project, with analysts expecting sizeable future revenue and earnings if development stays on track. At the same time, the company sits at an early stage of its journey, with limited current revenue, a recent loss, a high P/B multiple and a short cash runway, which all point to higher execution and funding risk. Board and management are relatively new, and recent insider selling and shareholder dilution raise questions about alignment. If these issues are managed well, the combination of production growth, resource scale and analyst upside expectations could be powerful, but the gap between the vision and today’s balance sheet is exactly what investors need to weigh.

Predictive Discovery’s growth story hinges on turning its West African gold portfolio into sustainable cash flow while managing funding pressure and dilution. Get the full context in the 2 key rewards and 4 important warning signs (2 are major!)

ASX:PDI Earnings & Revenue Growth as at Jul 2026
ASX:PDI Earnings & Revenue Growth as at Jul 2026

Telix Pharmaceuticals (ASX:TLX)

Overview: Telix Pharmaceuticals develops and sells radiopharmaceutical products that help doctors both detect and treat cancers more precisely, using targeted imaging agents and therapies for prostate, kidney, brain and other solid tumors in markets around the world.

Operations: Telix Pharmaceuticals generated about US$621.9m from Precision Medicine, US$245.1m from Manufacturing Solutions and US$9.3m from Therapeutics in the last period, with an inter segment elimination of US$72.5m.

Market Cap: A$4.92b

Telix Pharmaceuticals stands out in this screener because it already has meaningful commercial revenue from cancer imaging agents like Illuccix and Gozellix, while also building a deep treatment pipeline in prostate, kidney and brain cancers. Analysts highlight a gap between its current P/S multiple and their view of fair value, citing company guidance for roughly US$950m to US$970m in FY26 revenue and recent collaborations such as the Regeneron deal that broaden its technology reach. At the same time, Telix is still unprofitable, is spending heavily on R&D and manufacturing buildout, and faces regulatory, pricing and trial execution risk. The combination of existing cash flow and late stage trials may be of interest to long term growth focused investors who can tolerate these uncertainties.

Telix Pharmaceuticals is already generating substantial revenue, while its late stage cancer pipeline is still being priced in. Get a clearer view of how that growth story compares with expectations in the analyst forecasts for Telix Pharmaceuticals

ASX:TLX Earnings & Revenue Growth as at Jul 2026
ASX:TLX Earnings & Revenue Growth as at Jul 2026

Lindian Resources (ASX:LIN)

Overview: Lindian Resources is a Perth based explorer focused on rare earths, bauxite and gold, with its core Kangankunde Rare Earths project in Malawi and additional early stage assets across Africa and Australia.

Market Cap: A$1.41b

Lindian Resources is starting to move from story to execution, with first blasting now underway at Kangankunde and ore stockpiles being built ahead of targeted processing from Q4 2026. Forecasts for very strong earnings and revenue growth and the prospect of becoming profitable within three years are what attract growth focused investors. However, current revenue is tiny, losses have been widening and the company relies heavily on external funding. A refreshed board and new management team, supported by a regional Singapore office and in house legal capability, show a business that is still bedding down its structure while ramping a major project. For investors, the real question is how that mix of high growth potential and governance or funding risk could play out as Kangankunde moves toward production.

Lindian Resources is moving quickly from drilling results to real ore on the ground, yet the bigger story could be what happens next to earnings if forecasts prove directionally right. To get ahead of that potential inflection, check the analyst forecasts for Lindian Resources, including one factor that could completely change how you think about Kangankunde.

ASX:LIN Earnings & Revenue Growth as at Jul 2026
ASX:LIN Earnings & Revenue Growth as at Jul 2026

The three companies in this article are just a starting point. The full Fast Growing Stocks With High Insider Ownership screen uncovers 96 more stocks where insider conviction and analyst optimism line up in interesting ways through the Fast Growing Stocks With High Insider Ownership screener. Use Simply Wall St to identify, filter and analyze the specific catalysts and narratives that matter most to you so you can focus on the highest conviction opportunities that fit your approach.

Take Control of Your Investment Journey

If Telix Pharmaceuticals or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Before The Crowd Moves

Fresh ideas can start breaking out while most investors are still watching yesterday’s winners. Momentum can shift quickly, and under the radar for now stocks can change direction without much notice.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.